MedTrace Logo

Post Market Observational Trial for the PerQdisc Nucleus Replacement Device

NCT05105490 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-05-21

No results posted yet for this study

Summary

PerQdisc PMCF1 is a post-market clinical follow-up observational trial to follow subjects receiving a PerQdisc spinal implant for a duration of 5 years.

Conditions

  • Degenerative Disc Disease
  • Chronic Low-back Pain

Interventions

DRUG

PerQdisc

Observational trial to collect post-market safety and efficacy information in a limited number of human patients

Sponsors & Collaborators

  • Spinal Stabilization Technologies

    lead INDUSTRY

Principal Investigators

  • Michael Hess, MD · Spinal Stabilization Technologies

  • Jeff Golan, MD · Spinal Stabilization Technologies

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-31
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05105490 on ClinicalTrials.gov